510(k) Report

510(k) · Cleared

Cleared

Cryocheck Hex LA

K193556510(k) TraditionalCleared Oct 23, 2020305-day reviewClass II21 CFR 864.7925

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Precision Biologic · GFO Activated Partial Thromboplastin

Cleared on Oct 23, 2020 as substantially equivalent to K923731 (American Bioproducts Co., 1992) after a 305-day review. Its family tree reaches back 1 generation to 1992.

Decided
Oct 23, 2020
Review
305 days
Class
Class II
Product code
GFO
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K923731 (1992). No later device cites it as a predicate yet.

K923731 · Staclot LA Test Kit · American Bioproducts Co. · 1992 · recalled1990199520002005201020152020
  1. Root · 1 generation backK923731 Staclot LA Test KitAmerican Bioproducts Co. · 1992 · Recalled
  2. This deviceK193556 Cryocheck Hex LAPrecision Biologic · 2020
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K923731Staclot LA Test KitAmerican Bioproducts Co.19923
0 (this device)K193556Cryocheck Hex LAPrecision Biologic2020—
FIG. 1 — Lineage of K193556, 1992–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GFO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GFO device

  1. #1 K253957 HemosIL Silica Clotting Timescore 11.6 · 4 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K923731Staclot LA Test Kit
Summary page 4
…1 CFR 864.7290 Classification Panel Hematology Predicate Device Staclot LA (K923731) Indication for Use/ CRYOcheck Hex LA is for clinical laboratory use as a qualitative test kit Intended Use intend…
American Bioproducts Co.19923

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.

How does its category compare?

All GFO devices

GFO Activated Partial Thromboplastin: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · GFO

1in 2020

2016: 12020: 12026 (partial year): 1
2007high 1 (2016) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GFO

Too few GFO 510(k)s in any year since 2007 to give a median.

Recalls per year · GFO

1in 2025

2013: 12018: 22025: 1
2007high 2 (2018) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GFO

14in 2025

2011: 72013: 32014: 22015: 22016: 32017: 192018: 42019: 12021: 112023: 32024: 22025: 14
2007high 19 (2017) · low 0 (2007)2025

MAUDE reports naming product code GFO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—07
20120—00
20130—13
20140—02
20150—02
20161—03
20170—019
20180—24
20190—01
20201—00
20210—011
20220—00
20230—03
20240—02
20250—114
20261—0—

What is it indicated for?

Cryocheck Hex LA is for clinical laboratory use as a qualitative test kit intended to aid in the detection of lupus anticoagulants (LA) in 3.2% citrated human plasma by the application of hexagonal phase phospholipids. Cryocheck Hex LA should be used as an integrated test for lupus anticoagulant detection. For in vitro diagnostic use. The performance of this device has not been established in neonate and pediatric patient populations.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K193556: Cryocheck Hex LA.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K193556

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026